Coya Therapeutics, Inc. Common Stock

COYANASDAQ • USD
3.00 USD
↗ 0.00 (0.00%)🟢LIVE (AS OF 01:19 PM EST)
🟢Market: OPEN

Coya Therapeutics, Inc. Common Stock (COYA) is currently trading at $3.00. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. COYA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$2.99
High?$3.16
Low?$2.92
Prev. Close?$3.00
Volume?72.9K
Avg. Volume?169.2K
VWAP?$3.00
Rel. Volume?0.43x
Bid / Ask
Bid?$2.55 × 100
Ask?$3.48 × 100
Spread?$0.93
Midpoint?$3.01
Valuation & Ratios
Market Cap?70.4M
Shares Out?23.5M
Float?17.6M
Float %?75.2%
P/E Ratio?N/A
P/B Ratio?2.10
EPS?-$1.29
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Employees
8
Market Cap
73.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-12-29
Address
12645 MEMORIAL DR., SUITE F1 #305
HOUSTON, TX 77024
Phone: 650.739.3939
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
63
Momentum?
10
Short Sent.?
43
Piotroski F-Score?0/9Weak
Altman Z-Score?2.76Grey
Confidence?54%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?8.00%Elevated
Short Interest?1.4M
Days to Cover?11.9
Free Float17.6M
Avg Daily Volume118.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?7.24Strong
Quick Ratio?7.24Strong
Cash Ratio?6.64Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
72
2.10CHEAP▾
P/S?
Peers
100
S&P
3
15.01HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.1CHEAP▾
EV/Sales?
Peers
100
S&P
19
7.37HIGH▾
Returns & Efficiency
ROE?
S&P
3
-89.9%WEAK▾
ROA?
S&P
3
-76.7%WEAK▾
Cash Flow & Enterprise
FCF?$-21826758
Enterprise Value?$34.6M
Fundamentals ratios updated end of day